Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Antibodies and Larger Molecules

  • You have access
    Development of a Ga-68-labelled gastrin-based PET tracer for the detection of CCK2/gastrin receptor positive neuroendocrine tumors
    Maarten Brom, Lieke Joosten, Wim Oyen, Otto Boerman and M. Gotthardt
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 387;
  • You have access
    A protein scaffold based molecule for EGFR PET imaging
    Zheng Miao, Gang Ren, Hongguang Liu, Lei Jiang, Zhen Cheng and Sanjiv Gambhir
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 386;
  • You have access
    Pretargeted immunoPET for imaging colorectal cancer in a mouse model
    Rafke Schoffelen, Robert Sharkey, William McBride, Gerben Franssen, Annemarie Eek, Peter Laverman, Winette van der Graaf, Wim Oyen, David Goldenberg and Otto Boerman
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 381;
  • You have access
    Imaging CXCR4 expression in orthotopic and metastatic models of breast cancer
    Sridhar Nimmagadda, Mrudula Pullambhatla, James Fox, Gilbert Green and Martin Pomper
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 384;
  • You have access
    18F-Labeled C2A domain of synaptotagmin I and 18F-labeled recombinant human His10-annexin V as two potential PET tracers for the detection of cell death
    Feng Wang, Zizheng Wang and Wei Qu
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 385;
  • You have access
    Rapid internalization of novel single chain antibody targeting human prostate cancer cells
    Jiang He, Yong Wang, Jinjin Feng, Dongwei Gao, Arun Iyer, Henry VanBrocklin and Bin Liu
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 382;
  • You have access
    Anti-CD20 diabodies for targeting and imaging lymphoma
    Tove Olafsen, Shannon Sirk, David Betting, Vania Kenanova, Andrew Raubitschek, John Timmerman and Anna Wu
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 383;
SNMMI

© 2025 SNMMI

Powered by HighWire